| Nov 5 |
Vertex Pharmaceuticals Incorporated (VRTX) Q3 2024 Earnings Call Transcript
|
| Nov 4 |
Earnings Snapshot: Vertex Pharmaceuticals top Q3 estimates, raises FY revenue guidance
|
| Nov 4 |
Vertex Beats Expectations, But Needs More To Drive 'Another Leg Of Stock Upside'
|
| Nov 4 |
Vertex Pharmaceuticals (VRTX) Q3 Earnings and Revenues Top Estimates
|
| Nov 4 |
Vertex raises 2024 product revenue outlook following Q3 beats
|
| Nov 4 |
Vertex: Q3 Earnings Snapshot
|
| Nov 4 |
Vertex Pharma lifts annual revenue forecast on cystic fibrosis treatments strength
|
| Nov 4 |
Vertex Pharmaceuticals Non-GAAP EPS of $4.38 beats by $0.25, revenue of $2.77B beats by $80M
|
| Nov 4 |
Vertex Reports Third Quarter 2024 Financial Results
|
| Nov 4 |
Jim Cramer Says Vertex Doing 'Lord's Work': Can Q3 Earnings Outshine Bearish Charts?
|
